rejevity bpc-157 BPC-157 | Research Peptide |

Typically, the dose is increased every month until a long-term maintenance dose is reached, but the timeframe can be customized to your needs

Theoretical Tumor Growth Risk: BPC-157's angiogenic activity raises a theoretical concern that new blood vessel formation at tumor sites from existing or undetected malignancies accelerates tumor growth

It has been studied extensively in animal models for its ability to accelerate healing of tendons, ligaments, muscle, gut lining, and nerve tissue

USA 91 , 47314735 (1994)

Pure Bio Labs DIHEXA is a high-purity peptide formulation provided as 10mg capsules, intended exclusively for laboratory research and development use